- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 14.48M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $98.65M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $216.52M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $152.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $43.64M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $40.73M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $148.2M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $47.18M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $223.39M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $160.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $242.64M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $180.77M |
| Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 13.64M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.12M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$63.05M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $11.57M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $43.5M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$5.77 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$5.77 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $9.97M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $63.85M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$78.71M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$73.83M |